| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 08/27/2009 | CA2716326A1 Ultra-small rnas as toll-like receptor-3 antagonists |
| 08/27/2009 | CA2715765A1 Compositions for enhanced uptake of viral vectors in the myocardium |
| 08/26/2009 | EP2093294A1 Nucleotide and protein sequences of Nogo genes and methods based thereon |
| 08/26/2009 | EP2093292A2 Inhibition of specific histone deacetylase isoforms |
| 08/26/2009 | EP2091569A2 Targeted delivery of therapeutic agents with lyophilized matrices |
| 08/26/2009 | EP1734814A4 Tissue products derived from animals lacking any expression of functional alpha 1,3 galactosyltransferase |
| 08/26/2009 | EP1648481B1 Viral vectors |
| 08/26/2009 | EP1537875B1 C-terminal globular domain of adiponectin for use in the treatment of arteriosclerosis |
| 08/26/2009 | EP1536840B1 Formulation for inwardly transferring nucleic acids into eucaryotic cells |
| 08/26/2009 | EP1530584B1 Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses |
| 08/26/2009 | EP1503780B1 Androgen-regulated pmepa1 gene and methods of using the same to inhibit cancer cell growth |
| 08/26/2009 | EP1423428B1 Antibodies that block fgfr3 activation, methods of screening for and uses thereof |
| 08/26/2009 | EP1297005B1 Immunisation against chlamydia pneumoniae |
| 08/26/2009 | EP1296714B1 Combination of CpG and antibodies directed against CD19,CD20, CD22 or CD40 for the treatment or prevention of cancer. |
| 08/26/2009 | CN101517079A Non-replicating paramyxoviridae virus vector |
| 08/26/2009 | CN101517071A Meganuclease variants cleaving a DNA target sequence from a RAG gene and uses thereof |
| 08/26/2009 | CN101516908A Nucleic acids for expressing a polynucleotide of interest in mammalian cancer cells |
| 08/26/2009 | CN101516902A Polypeptides and polynucleotides encoding same and use thereof in the treatment of medical conditions associated with ischemia |
| 08/26/2009 | CN101516383A Methods and compositions for treating disease |
| 08/26/2009 | CN101513532A application of hBexl gene in preparation of tumor cell multidrug resistance reversal agents |
| 08/26/2009 | CN100532559C Virus envelope vector for gene transfer |
| 08/26/2009 | CN100532545C A method for producing recombinant viruses using site-specific recombination |
| 08/26/2009 | CN100532390C Oxygen deficient induction factor1 antisense oligonucleotide and its uses |
| 08/26/2009 | CN100531889C Process for producing coated fine particle |
| 08/26/2009 | CN100531802C Pseudo-type retrovirus vector containing membrane protein having hemagglutinin activity |
| 08/26/2009 | CN100531796C FGFR agonists |
| 08/25/2009 | US7579457 Sequence specific gene silencing; antisense agents |
| 08/25/2009 | US7579455 Antisense agents against genes coding for phosphodiesterase; for treatment of asthma, chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome, bronchitis, chronic bronchitis, silicosis, pulmonary fibrosis, lung allograft rejection, allergic rhinitis and chronic sinusitis |
| 08/25/2009 | US7579452 immunogenic composition comprising a polynucleotide encoding a nonfunctional mutant Brother of Regulator of Imprinted Sites (BORIS) protein; vaccine against cancer; biodrug delivery of specific nucleic acid |
| 08/25/2009 | US7579447 Antibodies against LLG polypeptides of the triacylglycerol lipase family |
| 08/25/2009 | US7579330 Methods of treating various cancers using melanoma differentiation associated protein-7 |
| 08/25/2009 | US7579328 DNA vaccination for treatment of multiple sclerosis and insulin-dependent diabetes mellitus |
| 08/25/2009 | US7579327 Isolated polynucleotide sequences; controlling neovasculization; cell growth regulators |
| 08/25/2009 | US7579326 Gene switch systems employing regulators with decreased dimerization |
| 08/25/2009 | US7579169 producing a mutant HH polypeptide by transforming isolated host cells with a vector capable of expressing the polypeptide from the nucleic acid sequence; diagnosis, prenatal screening and diagnosis, and therapies of blood disorders |
| 08/25/2009 | US7579141 Method of in vitro diagnosis which discriminates between exposure of a subject to Mycobacterium tuberculosis and vaccination with Bacille Calmette Guerin strain of Mycobacterium bovis, method comprising testing for presence of CD4 T lymphocytes that respond to MTBN4 |
| 08/25/2009 | US7578999 Antibodies specific for sclerostin |
| 08/25/2009 | CA2382521C Oligonucleotide n3'.fwdarw.p5' thiophosphoramidates: their synthesis and use |
| 08/25/2009 | CA2372456C Viral infection inhibitor targeting integrase n-terminal domain |
| 08/20/2009 | WO2009103067A2 Compositions and methods to treat asthma |
| 08/20/2009 | WO2009102894A2 Arginine-conjugated bioreducible poly (disulfide amine) polymers for gene delivery systems |
| 08/20/2009 | WO2009102820A2 Modified sugar substrates and methods of use |
| 08/20/2009 | WO2009102782A2 Increasing efficiency of nucleic acid delivery in vivo using targeting conjugates |
| 08/20/2009 | WO2009102488A2 A humanized model of membrane attack complex (mac) formation on murine retina and compositions, kits and methods for treatment of macular degeneration |
| 08/20/2009 | WO2009102465A2 Continuous cell programming devices |
| 08/20/2009 | WO2009102438A2 Aptamer inhibitors of osteopontin and methods of use thereof |
| 08/20/2009 | WO2009101204A2 Elimination of immune responses to viral vectors |
| 08/20/2009 | WO2009100645A1 Polycationic gene carriers formed of endogenous amino group-bearing monomers |
| 08/20/2009 | WO2009100502A1 Immunostimulatory sirna molecules |
| 08/20/2009 | WO2009076580A3 Compositions and methods for the treatment and prevention of cardiovascular diseases |
| 08/20/2009 | WO2009073104A3 Simian e adenoviruses sadv-39, -25. 2, -26, -30, -37, and -38 |
| 08/20/2009 | US20090210956 Composition and method for clusterin-mediated stem cell therapy for treatment of atherosclerosis and heart failure |
| 08/20/2009 | US20090210954 Genes |
| 08/20/2009 | US20090209747 Method to inhibit cell growth using oligonucleotides |
| 08/20/2009 | US20090209730 Method for gene transfer into target cells with retrovirus |
| 08/20/2009 | US20090209729 Recombinant chemokine-antigen vaccine |
| 08/20/2009 | US20090209631 Method for enhanced uptake of viral vectors in the myocardium |
| 08/20/2009 | US20090209630 Vectors carrying coding sequences for angiogenic agents such as Del-1or VEGF formulated with poloxamers to improve bioavailability; avoids problems with toxicity inherent to existing delivery technologies; treating ischemia in a muscle, kidney or brain tissue |
| 08/20/2009 | US20090209629 Nucleic Acid Functionalized Nanoparticles for Therapeutic Applications |
| 08/20/2009 | US20090209627 RNAi-MEDIATED INHIBITION OF CONNEXIN 43 FOR TREATMENT OF IOP-RELATED CONDITIONS |
| 08/20/2009 | US20090209626 Duplex Oligonucleotides with Enhanced Functionality in Gene Regulation |
| 08/20/2009 | US20090209625 Modulation of chrebp expression |
| 08/20/2009 | US20090209624 Compositions and their uses for gene therapy of bone conditions |
| 08/20/2009 | US20090209623 Anti-sense nucleic acid derived from organism |
| 08/20/2009 | US20090209619 Depression of herg k+ channel function in mammallan cells and applications to the control of cancer cells division |
| 08/20/2009 | US20090209037 Viral core protein-cationic lipid-nucleic acid-delivery complexes |
| 08/20/2009 | US20090209034 Tumour rejection antigens |
| 08/20/2009 | US20090209033 Immortalized hepatocyte cell line secreting modified insulin with glucose sensitivity |
| 08/20/2009 | US20090209006 Taci-immunoglobulin fusion proteins |
| 08/20/2009 | US20090208969 Polynucleotides and Polypeptides Encoding Receptors |
| 08/20/2009 | US20090208963 Gene Involved in V(D)J recombination and/or DNA repair |
| 08/20/2009 | US20090208518 Immunogenic peptides for the treatment of prostate and breast cancer |
| 08/20/2009 | US20090208504 Polypeptides involved in immune response |
| 08/20/2009 | US20090208486 Pharmaceutical composition comprising cxcr3 inhibitor |
| 08/20/2009 | US20090208467 P27 and p21 in gene therapies |
| 08/20/2009 | US20090208462 Methods of Treatment |
| 08/20/2009 | US20090208460 Mutant Herpes Simplex Viruses Comprising Nucleic Acid Encoding A Nitroreductase |
| 08/20/2009 | US20090208459 Methods of treating anemia using recombinant adeno-associated virus virions |
| 08/20/2009 | US20090208419 Multimodality Imaging of Reporter Gene Expression Using a Novel Fusion Vector in Living Cells and Animals |
| 08/20/2009 | CA2715484A1 Elimination of immune responses to viral vectors |
| 08/20/2009 | CA2715460A1 Continuous cell programming devices |
| 08/20/2009 | CA2715373A1 A humanized model of membrane attack complex (mac) formation on murine retina and compositions, kits and methods for treatment of macular degeneration |
| 08/20/2009 | CA2714535A1 Aptamer inhibitors of osteopontin and methods of use thereof |
| 08/19/2009 | EP2090654A1 PARTIAL FRAGMENT OF REIC/Dkk-3 GENE AND THERAPEUTIC AGENT FOR CANCER CONTAINING THE SAME |
| 08/19/2009 | EP2090589A1 Albumin-fused Kunitz domain peptides |
| 08/19/2009 | EP2090317A1 Method of preventing or treating diabetes |
| 08/19/2009 | EP2089521A1 Soluble tnf receptors and their use in treatment of disease |
| 08/19/2009 | EP2089412A2 Suppression of mitochondrial oxidative stress |
| 08/19/2009 | EP2089411A2 Compositions and methods to treat cancer with cupredoxins and cpg rich dna |
| 08/19/2009 | EP2089061A1 Inhibition of sox9 function fn the treatment of proteogl ycan-associated pathophysiological conditions |
| 08/19/2009 | EP1497467B1 Oligonucleotides from sequences coding for the surface component of ptlv envelope proteins and uses thereof |
| 08/19/2009 | EP1362096B1 Pigmentary epithelium cell of the eye, the production thereof and the use of the same for treating diseases of the eye or of the central nervous system |
| 08/19/2009 | EP1255829B1 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization |
| 08/19/2009 | EP0942987B1 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes |
| 08/19/2009 | CN101509009A Amalgamation gene of hepatitis B virus L gene and Ag85B, construction and uses of its expression vector |
| 08/19/2009 | CN101509008A Amalgamation gene of hepatitis B virus L gene and hGM-CSF, construction and uses of its expression vector |
| 08/19/2009 | CN101509002A Recombinant rubella virus protein and uses thereof |
| 08/19/2009 | CN101508999A Recombinant toxoplasma protein and uses thereof |
| 08/19/2009 | CN101508989A Radiation sensibility tumor-targeted promotor and uses thereof |
| 08/19/2009 | CN101508979A Recombinant adenovirus carrying human lactoferrin, preparation and uses thereof |